These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10083405)

  • 41. Comparison of the effect of a 5-mg/kg and 10-mg/kg cyclosporine loading dose with single and multiple donor-specific transfusions on rat cardiac allograft survival.
    Fisher RA; Cohen DS; Alexander JW; Davies CB; Schroeder TJ
    Transplant Proc; 1994 Oct; 26(5):3056-9. PubMed ID: 7940961
    [No Abstract]   [Full Text] [Related]  

  • 42. Origin, occurrence, and function of microchimeric cells: V. Quantitative aspects of microchimerism following pancreaticoduodenal transplantation model in rats.
    Suzuki K; Kazui T; Kawabe A; Yan H; Li XK; Kitazawa Y; Amemiya H; Suzuki S; Kimura H
    Transplant Proc; 1998 Nov; 30(7):3849. PubMed ID: 9838683
    [No Abstract]   [Full Text] [Related]  

  • 43. Long-term survival of limb allografts after weaning of cyclosporine: possible role of microchimerism.
    Durlik M; Lukomska B; Namysłowski A; Janczewska S; Cybulska E; Olszewski WL
    Transplant Proc; 1997; 29(1-2):1226-7. PubMed ID: 9123285
    [No Abstract]   [Full Text] [Related]  

  • 44. Biological aspects of limb transplantation: I. Migration of transplanted bone marrow cells into recipient.
    Olszewski WL; Interewicz B; Maksymowicz M; Durlik M
    Plast Reconstr Surg; 2003 Nov; 112(6):1628-35. PubMed ID: 14578794
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The difficulty of eliminating donor leukocyte microchimerism in rat recipients bearing established organ allografts.
    Kiyomoto T; Toyokawa H; Nakao A; Kaizu T; Demetris AJ; Starzl TE; Murase N
    Transplantation; 2006 Feb; 81(3):438-44. PubMed ID: 16477232
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Donor bone marrow potentiates the effect of tacrolimus on nonvascularized heart allograft survival: association with microchimerism and growth of donor dendritic cell progenitors from recipient bone marrow.
    Khanna A; Steptoe RJ; Antonysamy MA; Li W; Thomson AW
    Transplantation; 1998 Feb; 65(4):479-85. PubMed ID: 9500620
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy.
    Shizuru JA; Seydel KB; Flavin TF; Wu AP; Kong CC; Hoyt EG; Fujimoto N; Billingham ME; Starnes VA; Fathman CG
    Transplantation; 1990 Sep; 50(3):366-73. PubMed ID: 1976282
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
    Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
    Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative analysis of microchimerism with Y-chromosome-specific PCR in canine small bowel transplantation.
    Okuda T; Ichikawa N; Zhu Y; Chun HJ; Demestris AJ; Nalesnik MA; Rudert B; Trucco M; Starzl TE; Murase N
    Transplant Proc; 2000 Sep; 32(6):1278. PubMed ID: 10995945
    [No Abstract]   [Full Text] [Related]  

  • 50. Different routes of donor-derived hematopoietic stem cell transplantation for donor-specific chimerism induction across MHC barrier.
    Siemionow MZ; Klimczak A; Unal S
    Transplant Proc; 2005; 37(1):62-4. PubMed ID: 15808547
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reassessment of the role of CD8+ T cells in the induction of allograft tolerance by donor-specific blood transfusion.
    Douillard P; Vignes C; Josien R; Chiffoleau E; Heslan JM; Proust V; Soulillou JP; Cuturi MC
    Eur J Immunol; 1999 Jun; 29(6):1919-24. PubMed ID: 10382754
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peripheral donor leukocytes prolong survival of rat renal allografts.
    Noris M; Azzollini N; Mister M; Pezzotta A; Piccinini G; Casiraghi F; Cugini D; Perico N; Orisio S; Remuzzi G
    Kidney Int; 1999 Sep; 56(3):1101-12. PubMed ID: 10469380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clonal expansion of T lymphocyte lineage cells in microchimeric cells.
    Suzuki K; Kazui T; Kawabe A; Yan H; Li XK; Kitazawa Y; Amemiya H; Suzuki S; Kimura H
    Transplant Proc; 1998 Nov; 30(7):3879-80. PubMed ID: 9838697
    [No Abstract]   [Full Text] [Related]  

  • 54. Donor-specific tolerance by perioperative intrathymic injection of bone marrow cells in the rat cardiac allograft model: use of FK506 can shorten the necessary duration of pretransplant intrathymic conditioning.
    Ito A; Ito T; Kamiike W; Moriguchi A; Ohkawa A; Uchikoshi F; Tanaka S; Nakata S; Matsuda H
    Transplantation; 1997 Sep; 64(5):752-7. PubMed ID: 9311715
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hearts lacking donor-type APCs develop cardiac allograft vasculopathy.
    McLean AD; Krasinskas AM; Eiref SD; Popma SH; Moore JS; Hruban RH; Rosengard BR
    Transplant Proc; 1999; 31(1-2):135. PubMed ID: 10083045
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of recombinant interferon gamma and interleukin-2 and of a monoclonal antibody against interferon gamma on the rat immune response against heart allografts.
    Paineau J; Priestley C; Fabre J; Chevalier S; van der Meide P; Schellekens H; Jacques Y; Soulillou JP
    J Heart Lung Transplant; 1991; 10(3):424-30. PubMed ID: 1906747
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduction in donor-specific cytotoxic T lymphocytes and prolonged cardiac allograft survival following intrathymic donor splenocyte injection.
    Goss JA; Nakafusa Y; Yu S; Flye MW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):286-8. PubMed ID: 8438302
    [No Abstract]   [Full Text] [Related]  

  • 58. Regeneration of Schwann cells during extrinsic hepatic reinnervation following liver transplantation in rats.
    Sakamoto I; Takahashi T; Ueno T; Kakita A; Hayashi I; Yamashina S
    Transplant Proc; 2003 Feb; 35(1):573-4. PubMed ID: 12591537
    [No Abstract]   [Full Text] [Related]  

  • 59. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
    Arima T; Lehmann M; Flye MW
    Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neonatal bone fragments for the induction of xenograft acceptance: transplantation of xenogeneic hematopoietic stem cells and species-specific microenvironment for hematopoiesis.
    Murase N; Ye Q; Sakamoto T; Demetris AJ; Llull R; Starzl TE
    Transplant Proc; 1997; 29(1-2):1201. PubMed ID: 9123271
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.